phone icon  Int'l : +1 (503) 505-6949
Shopping Cart is Empty..
$ 0

Automated Microscopy Market

- Opportunities and Forecasts, 2014 -2020
 Report Code: ME 1572
 Pages: NA
 Format: PDF Exel CD_rom
pub_n Upcoming Date: Dec 2015
tab_nTables: NA

Microscopy is the technology that focuses on magnifying the images of small biological specimen. Automated microscopy is an advance technology that uses advance monitoring techniques such as atomic force microscopy (afm) and raman confocal systems, that enhance monitoring of biological specimen. Global microscopy market was accounted to $2.7 billion in 2010. Development of user friendly and less complex microscope are driving the growth for automated microscopy market. The global market for automated microscopy is dominated by higher cost restraint. The high cost required for digital setup is decreasing the growth for automated microscopy market. However, increase in technological advancements will influence the cost of the equipments, which will affect the price of the microscopy setup. The cost for an average automated microscope varies from $5,000-$15,000. 

Global automated microscopy market is challenged by conventional microscopy. However, lower cost of conventional microscopy is acting as a competitive advantage. This report provides comparative intelligence about conventional and automated microscopy. The report provides market trends for automated microscopy market and expected transition of these trends in future

The key company profiles included are Olympus Corp., Nikon Corp., Hitachi High Technologies Ltd., Fei Company, Carl Zeiss, Bruker Corporation, Agilent Technologies Inc., Asylum Research

KEY BENEFITS• Market estimation for products, applications, end-users and geographic segment is derived from current market scenario and expected market trends.• The report provides an in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to identify opportunities in specific regions• Impact analysis of top 10 factors to provide market situation to key decision makers of the automated microscopy market• Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report• SWOT analysis and strategic developments included in the report for key market players are included in the report to get better understanding of potential opportunities and challenges for companies 


GLOBAL MARKET,  BY PRODUCTS• Inverted Microscope• Fluorescence Microscope• Electron Microscope• Scanning Probe Microscope• Optical Microscope• Others

GLOBAL MARKET, BY APPLICATIONS• Nanotechnology• Medical Diagnostics• Life science monitoring• Material Science• Semiconductors• Others

GLOBAL MARKET, BY END-USERS• Hospitals• Research Facilities• Diagnostic Clinics• Medical equipment leasing companies

GLOBAL MARKET, BY GEOGRAPHIES• North America• Europe• Asia-Pacific• RoW

KEY AUDIENCES• Diagnostic Laboratories• Research based pharmaceutical companies• Government and Private Institutes• Academic Institutes

Let us know more about your research need and we will customize an offer exclusively for you!

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
Need to add more ?

Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
Need More Information
phone_n +1 (503) 505-6949

Help AMR
Send Enquiry
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
  • ...
    IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.
    Jun 2015 | Price: $4830(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
    May 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Sexually Transmitted Diseases (STDs) are also known as Venereal diseases (VDs) or Sexually Transmitted Infections (STIs). A variety of methods have been employed for diagnosis of STDs that differ based on the type of disease. The objective of this report is to provide an in-depth understanding of diagnostic tests of STDs. The market diagnostic testing of STDs was valued at $96.7 billion in 2013 with a corresponding test volume of 4,204 million.
    Nov 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests.
    Sep 2014 | Price: $2625(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain. Antiepileptics market is specifically driven due to new drug approvals over the past few years. However, recent patent expiration of major brand such as Lamictal is expected to hinder the growth of the market. GlaxoSmithKline, Johnson & Johnson, Sanofi, Pfizer, Novartis, Abbott, Sunovion Pharmaceuticals, and Cephalon are some of the key leaders of global antiepileptic drugs market.
    Nov 2015 | View Details >>
  • ...
    Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases
    Nov 2015 | View Details >>
  • ...
    Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms in the cervix region of the female reproductive system. The cancer is usually a slow developing type of cancer which may or may not show symptoms of the diseases.
    Nov 2015 | View Details >>
  • ...
    Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian cancer drugs, which would contribute to the growth of the market. It focuses on both generic and brand drugs that are used to treat ovarian cancer and their impact on the market. The market is driven by the increasing incidence of ovarian cancer. The need for more effective treatment options is pushing growth of the market. While the market is dominated by generics such as paclitaxel and carboplatin, it is expected that drugs such as Bevacizumab (Avastin), Pazopanib (Votrient) would boost the growth of this market. Development of drugs with improved efficacy is a challenge for this market. The opportunity for this market lies in developing new drugs for treating ovarian cancer.
    Nov 2015 | View Details >>